We are committed to revolutionizing transfection technologies, making them tailored, accessible, and affordable

ONE PLATFORM ALL POSSIBILITIES

OUR MISSION

Pioneering the future of genetic medicine

Vectorialis is revolutionizing nucleic acid therapeutics from lab to clinic, targeting genetic disorders, infectious diseases, and cancer

Our VibroFect® technology democratizes genetic medicine, empowering researchers worldwide to break barriers and accelerate breakthroughs

We’re transforming patient care through genetic medicine’s full potential

Ready to accelerate your genetic medicine research? Experience VibroFect® now!

DISCOVER OUR TECHNOLOGY

OUR HISTORY

A revolution inspired by innovation and opportunity

Years of relentless research and innovation. One transformative breakthrough: VibroFect®

Every great innovation begins with a challenge. We experienced firsthand what every researcher knows: nucleic acid delivery needed a revolution. Low efficiency, unpredictable results, and toxicity concerns weren't just obstacles; they were opportunities to pioneer something extraordinary

That vision drove us to create VibroFect®. Our patented platform combines mechanical stimulation with precision-engineered reagents to generate highly effective nanoparticles, transforming nucleic acid delivery from a source of frustration into a success. We’ve turned decades-old limitations into groundbreaking solutions

Today, VibroFect® empowers researchers worldwide with superior transfection efficiency, unprecedented reliability, and the confidence to advance genetic medicine

From challenge to breakthrough, from vision to reality

Experience the VibroFect® revolution now!

EXPLORE ALL DEVELOPMENT STAGES

OUR TEAM

  • Nina BONO

    Ph.D.

    Co-founder

    CEO

    Read Bio

  • Gabriele CANDIANI

    Ph.D.

    Co-founder

    PRESIDENT & CTO

    Read Bio

  • Dario CALEFFI

    MBA

    Business strategy & Fundrising

    Read Bio

CUSTOMER & USER REVIEWS

Postdocs

“My efficiency rates went from 36% to 73%” - Hellen, ViRNA user

“I’ve tried every transfection method out there. VibroFect is the only one that works reliably across different cell lines” - John, ViALL user

Ph.D. students

“VibroFect saved my thesis. Consistent results every single time with no more failed experiments” - Sophia, ViALL & ViRNA user

“Consistent as my coffee addiction!” - Sarah, ViALL user

Lab manager

“Reproducible, reliable, totally viable!” & “Training new students is so much easier now. VibroFect just works: no steep learning curve” - Paul, ViALL user

Sr. scientits & professors

“Primary neurons? No problem. Stem cells? Easy. VibroFect handles what others can't” - Stefania, ViRNA customer

“VibroFect data is publication-ready every time. Reviewers love the consistency” - Silvie, ViALL customer

“The system paid for itself in two months by eliminating costly experimental failures” - Elena, ViPRO customer

NEWS

  • CRS 2025 Annual meeting and Exposition

    Controlled Release Society 2025 congress

    Philadelphia, USA

    READ MORE

  • CRS 2024 Annual meeting and Exposition

    Controlled Release Society 2024 congress

    Bologna, Italy

    READ MORE

  • ETPN 2024 congress

    European Technology Platform on Nanomedicine 2024 congress

    Milan, Italy

    READ MORE

  • Premio 2031:  Fondazione Toscana Life Sciences

    Siena, Italy

    READ MORE

  • Switch 2 Product: PoliHUB innovation challenge

    Milan, Italy

    READ MORE

  • Janssen Grant

    READ MORE

  • ITALIAN TECH WEEK

    2023

    Turin, Italy

    READ MORE

  • Startcup Lombardia

    Startup competition

    Milan, Italy

    Clicca qui

FUNDING & PARTNERS